The research was easy, but the development required billions of dollars and literal war-time production efforts (in the US the Defense Production Act was invoke

The research was easy, but the development required billions of dollars and literal war-time production efforts (in the US the Defense Production Act was invoked). Drug regulators are also very conservative. Why take risk on making a low-margin mRNA influenza vaccine when other platforms are good enough?